Synopsys Net Worth
Synopsys Net Worth Breakdown | SNPS |
Synopsys Net Worth Analysis
Synopsys' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Synopsys' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Synopsys' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Synopsys' net worth analysis. One common approach is to calculate Synopsys' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Synopsys' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Synopsys' net worth. This approach calculates the present value of Synopsys' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Synopsys' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Synopsys' net worth. This involves comparing Synopsys' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Synopsys' net worth relative to its peers.
Enterprise Value |
|
To determine if Synopsys is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Synopsys' net worth research are outlined below:
Synopsys is unlikely to experience financial distress in the next 2 years | |
Over 79.0% of the company shares are owned by institutional investors | |
Latest headline from benzinga.com: Insider Trading |
Synopsys Quarterly Good Will |
|
Synopsys uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Synopsys. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Synopsys' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of February 2024 Upcoming Quarterly Report | View | |
15th of May 2024 Next Financial Report | View | |
31st of January 2024 Next Fiscal Quarter End | View | |
4th of December 2024 Next Fiscal Year End | View | |
31st of October 2023 Last Quarter Report | View | |
31st of October 2023 Last Financial Announcement | View |
Know Synopsys' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Synopsys is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Synopsys backward and forwards among themselves. Synopsys' institutional investor refers to the entity that pools money to purchase Synopsys' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Van Eck Associates Corporation | 2025-03-31 | 2 M | Ameriprise Financial Inc | 2025-03-31 | 2 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.8 M | Ubs Asset Mgmt Americas Inc | 2025-03-31 | 1.8 M | Alliancebernstein L.p. | 2025-03-31 | 1.7 M | Northern Trust Corp | 2025-03-31 | 1.6 M | Sustainable Growth Advisers, Lp | 2025-06-30 | 1.5 M | Amvescap Plc. | 2025-03-31 | 1.5 M | Clearbridge Advisors, Llc | 2025-03-31 | 1.5 M | Vanguard Group Inc | 2025-03-31 | 14.8 M | Blackrock Inc | 2025-03-31 | 13.3 M |
Follow Synopsys' market capitalization trends
The company currently falls under 'Mega-Cap' category with a current market capitalization of 114.01 B.Market Cap |
|
Project Synopsys' profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.22 | 0.23 | |
Return On Capital Employed | 0.17 | 0.15 | |
Return On Assets | 0.20 | 0.21 | |
Return On Equity | 0.29 | 0.30 |
When accessing Synopsys' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Synopsys' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Synopsys' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Synopsys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Synopsys. Check Synopsys' Beneish M Score to see the likelihood of Synopsys' management manipulating its earnings.
Evaluate Synopsys' management efficiency
Synopsys has return on total asset (ROA) of 0.0467 % which means that it generated a profit of $0.0467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1555 %, meaning that it created $0.1555 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Synopsys' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.21 in 2025, whereas Return On Capital Employed is likely to drop 0.15 in 2025. At this time, Synopsys' Return On Tangible Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.29 in 2025, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 53.03 | 55.68 | |
Tangible Book Value Per Share | 31.61 | 33.19 | |
Enterprise Value Over EBITDA | 34.97 | 36.72 | |
Price Book Value Ratio | 10.06 | 6.38 | |
Enterprise Value Multiple | 34.97 | 36.72 | |
Price Fair Value | 10.06 | 6.38 | |
Enterprise Value | 44.6 B | 46.9 B |
Effective leadership at Synopsys drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 17.8576 | Revenue | Quarterly Revenue Growth 0.103 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Synopsys insiders, such as employees or executives, is commonly permitted as long as it does not rely on Synopsys' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Synopsys insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Synopsys Corporate Filings
F4 | 4th of August 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 24th of July 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
23rd of July 2025 Other Reports | ViewVerify | |
8K | 17th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Synopsys Earnings per Share Projection vs Actual
Synopsys Corporate Management
Shankar Krishnamoorthy | Head Development | Profile | |
Shelagh Glaser | Chief Officer | Profile | |
Charlie Matar | Senior Group | Profile | |
John Runkel | General Counsel and Corporate Secretary | Profile | |
Deirdre Hanford | Chief Officer | Profile |
Additional Tools for Synopsys Stock Analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.